BeStock  

Steris PLC STE

US equityMarket cap rank #788Medical Devices
$255.76 +$1.00 (+0.39%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $255.76 0.00%
Open$257.05
Prev close$254.76
Day range$254.99 – $259.35
Volume823.5K
Market cap$24.84B
P/E (TTM)30.4
Dividend yield1.01%

Earnings

Average move on report day±5.3%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+9.8%
Worst reaction-10.9%

Stock move on the day after each report

-2.5%2024/Q3+7.6%2024/Q4-2.4%2025/Q1-5.3%2025/Q2+2.1%2025/Q3+8.5%2025/Q4+6.8%2026/Q1+6.9%2026/Q2-7.7%2026/Q3+4.5%2026/Q4-0.4%2027/Q1+2.5%2027/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2027/Q24 Nov 2026After Market±5.5%+2.50%Within range
2027/Q15 Aug 2026After Market±5.2%-0.40%Within range
2026/Q411 May 2026After Market±4.6%+4.46%Within range
2026/Q34 Feb 2026After Market±5.6%-7.74%Bigger than priced
2026/Q25 Nov 2025After Market±5.7%+6.94%Bigger than priced
2026/Q16 Aug 2025After Market±6.5%+6.79%Bigger than priced
2025/Q414 May 2025After Market±6.4%+8.52%Bigger than priced
2025/Q35 Feb 2025After Market±6.1%+2.09%Within range
2025/Q26 Nov 2024After Market±5.9%-5.28%Within range
2025/Q16 Aug 2024After Market±6.9%-2.36%Within range
2024/Q48 May 2024After Market±6.6%+7.57%Bigger than priced
2024/Q37 Feb 2024After Market±7.4%-2.48%Within range
2024/Q27 Nov 2023After Market±6.1%-5.46%Within range
2024/Q11 Aug 2023After Market±7.2%+1.69%Within range
2023/Q410 May 2023After Market±6.7%+9.83%Bigger than priced
2023/Q38 Feb 2023After Market±5.5%-10.89%Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2027/Q2

By business line

  • Healthcare$1.12B 70.7%
  • Applied Sterilization Technologies (AST)$295.60M 18.6%
  • Life sciences$170.60M 10.7%

Latest reported quarter: Q2, ended Sep 2026

Revenue$1.59B+8.8% YoY
Operating profit$313.30M+16.9% YoY
Net profit$214.10M+11.2% YoY
Diluted EPS$2.19+12.9% YoY
Free cash flow$212.90M+5.8% YoY
Operating cash flow$289.00M

Revenue, last 8 quarters

$1.4BDec '24$1.5BMar '25$1.4BJun '25$1.5BSep '25$1.5BDec '25$1.6BMar '26$1.5BJun '26$1.6BSep '26

Net profit, last 8 quarters

$173.3MDec '24$146.1MMar '25$178.0MJun '25$192.5MSep '25$194.3MDec '25$220.3MMar '26$201.0MJun '26$214.1MSep '26

Profitability & balance sheet

Gross margin44.6%
Operating margin19.3%
Net margin13.4%
Return on equity11.6%
Return on assets7.8%
Return on invested capital9.4%
Current ratio2.05
Liabilities / assets32.1%
Cash & investments$531.10M
Total debt$2.01B
Net cash (debt)-$1.48B
Free cash flow / sales15.2%

Discussion

No comments yet — be the first to weigh in on STE.

Sign in to join the discussion.

Scroll to Top